{"sourcedb":"DevicePMAs@therightstef","sourceid":"P020001_S006","text":"Approval for changes to the clinical guidelines.  The device asmodified will be marketed under the trade name stan s31 fetal heart monitor and is indicated for use as an adjunct to fetal heart rate monitoring to determine whether obstetrical intervention is warranted when there is increased risk of developing metabolic acidosis. this device is intended for use in patients with: 1) planned vaginal delivery; 2) \u003E36 completed weeks gestation; 3) singleton fetus; 4) vertex presentation; and5) ruptured amniotic membranes.","project":"consensus_PMA_Age_Indications"}